ANI Pharmaceuticals, Inc. (ANIP) |
| 71.46 0.76 (1.07%) 09-10 16:00 |
| Open: | 70.35 |
| High: | 71.48 |
| Low: | 70.07 |
| Volume: | 228,888 |
| Market Cap: | 1,625(M) |
| PE Ratio: | 8.69 |
| Exchange: | NASDAQ |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 83.21 |
| Resistance 1: | 78.16 |
| Pivot price: | 73.15 |
| Support 1: | 70.00 |
| Support 2: | 58.24 |
| 52w High: | 99.39 |
| 52w Low: | 69.96 |
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
| EPS | 4.590 |
| Book Value | 27.870 |
| PEG Ratio | 0.00 |
| Gross Profit | 25.740 |
| Profit Margin (%) | 11.07 |
| Operating Margin (%) | 14.97 |
| Return on Assets (ttm) | 5.4 |
| Return on Equity (ttm) | 20.5 |
Thu, 10 Sep 2026
ANIP: Record growth in rare disease and generics, with strong financials and strategic expansion - TradingView
Thu, 10 Sep 2026
ANIP: Rare disease assets and strategic expansion fuel multi-year growth and strong financial outlook - TradingView
Wed, 09 Sep 2026
ANI Pharmaceuticals (NASDAQ:ANIP) Sets New 52-Week Low - Time to Sell? - MarketBeat
Wed, 09 Sep 2026
ANI Pharmaceuticals (NASDAQ:ANIP) Earns Outperform Rating from Analysts at Leerink Partners - MarketBeat
Sat, 05 Sep 2026
Legal & General Group Plc Buys Shares of 45,075 ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
Fri, 04 Sep 2026
ANI Pharmaceuticals (ANIP) Appoints Henry Gosebruch To Its Board - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |